| |
| |
|
| Insider
Information: |
Jones Michael L |
| Relationship: |
Exec. Director, Financ... |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
16,653 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$74,605 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
16,653 |
|
|
| Total
Value |
$74,605 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
Exec. Director, Financ... |
2022-12-19 |
16,653 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
Exec. Director, Finance - PAO |
• • – |
2022-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,900 |
16,653 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Exec. Director, Finance - PAO |
• • – |
2022-12-15 |
4 |
AS |
$10.90 |
$4,851 |
D/D |
(445) |
10,753 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Exec. Director, Finance - PAO |
• • – |
2022-12-01 |
4 |
OE |
$1.42 |
$12,212 |
D/D |
8,600 |
19,798 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Exec. Director, Finance - PAO |
• • – |
2022-12-01 |
4 |
S |
$13.01 |
$111,886 |
D/D |
(8,600) |
11,198 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Exec. Director, Finance - PAO |
• • – |
2022-03-01 |
4 |
OE |
$4.73 |
$10,879 |
D/D |
2,300 |
13,498 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Exec. Director, Finance - PAO |
• • – |
2022-03-01 |
4 |
S |
$17.20 |
$39,560 |
D/D |
(2,300) |
11,198 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Exec. Director, Finance - PAO |
• • – |
2021-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,850 |
11,198 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Exec. Director, Finance - PAO |
• • – |
2021-03-18 |
4 |
OE |
$3.51 |
$15,795 |
D/D |
4,500 |
5,348 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Exec Director, Finance - PAOOf |
• – – |
2020-01-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
848 |
|
% |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
